Transcriptional Factor SOX2, LncRNA HBL1, microRNA1 and PRC2 Epigenetic Complex Compose a Network to Orchestrate Cardiac Differentiation from Human Pluripotent Stem Cells
转录因子 SOX2、LncRNA HBL1、microRNA1 和 PRC2 表观遗传复合物组成一个网络来协调人类多能干细胞的心脏分化
基本信息
- 批准号:10242624
- 负责人:
- 金额:$ 48.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:BindingCRISPR/Cas technologyCardiacCardiac MyocytesCardiac developmentCardiovascular systemCell NucleusCellsChIP-seqComplexCongenital Heart DefectsCytoplasmDevelopmentDrosophila genusElectrophysiology (science)Epigenetic ProcessExhibitsGene ExpressionGenesGeneticGenetic TranscriptionHeartHeterogeneityHumanKnock-outLaboratoriesMediatingMesodermMessenger RNAMicroRNAsModificationMolecularMorphogenesisMusNamesNuclearOrganogenesisOutcomePathogenicityPathway interactionsPlayPluripotent Stem CellsPolycombPropertyProteinsRecording of previous eventsRegulator GenesRoleSignal TransductionStem Cell ResearchStretchingTestingTissuesTranscriptUntranslated RNAXenopuscardiogenesiscell fate specificationhistone modificationhuman pluripotent stem cellhuman stem cellsinduced pluripotent stem cellknock-downnoveloverexpressionpluripotencyprogenitorprogramspromotersingle-cell RNA sequencingtranscription factortranscriptome
项目摘要
PROJECT SUMMARY/ABSTRACT
During the past decades, studies of heart development have been mainly focused on conserved gene
regulatory mechanisms, which control various aspects of cardiogenesis across multiple species from
drosophila to mouse. These conserved gene programs include cardiac transcriptional factors (such as Nkx2.5,
Isl1, Tbx20), microRNAs, and epigenetic regulators. Despite the high evolutionary conservation of
cardiogenesis, the human heart exhibits unique properties, including distinctive morphogenesis and
electrophysiological properties. These species-specific differences suggest the existence of novel genetic
programs in each species. As the limitation of experimental setting, it remains unclear the mechanisms that
regulate unique aspects of human cardiogenesis, and how human-specific mechanisms interact with
conserved gene programs to fine-tune human heart development. Recently, accumulating evidence
demonstrated that long noncoding RNAs (lncRNAs) play important roles in cell fate specification and
organogenesis, including the heart. LncRNAs are greater than 200bp non-coding transcripts, which account for
>40% of human transcriptome. Many lncRNAs are tissue-specific and species-specific. Recently, we identified
a novel human-specific lncRNA, named Heart Brake LncRNA1 (HBL1) (Dev. Cell. 2017, 4:333-8). HBL1 is
highly expressed in both cytoplasm and nucleus of human induced pluripotent stem cells (hiPSCs). Cytosolic
HBL1 modulates cardiomyocyte (CM) development from hiPSCs by counteracting microRNA1 (MIR1).
Pluripotency marker gene SOX2 activates HBL1 transcription. In this proposal, we will analyze further, a novel
mechanism of nuclear HBL1 in initiating the cardiac gene-expressing program via interacting with polycomb
repressive complex 2 (PRC2). Additionally, we will test a hypothesis that HBL1 adds a new layer of human-
specific regulatory mechanism on top of a conserved cardiogenic axis. All together, the central hypothesis is
that transcriptional factor SOX2, lncRNA HBL1, microRNA-1 and PRC2 complex composite a whole network to
control human cardiogenesis from pluripotent stem cells.
项目摘要/摘要
在过去的几十年里,心脏发育的研究主要集中在保守基因上。
调控机制,控制多个物种心脏发生的各个方面
从果蝇到老鼠。这些保守的基因程序包括心脏转录因子(例如Nkx2.5,
Is11、Tbx20)、microRNAs和表观遗传调控因子。尽管在进化上高度保守
心脏发生,人类心脏表现出独特的特性,包括独特的形态发生和
电生理特性。这些物种特有的差异表明了新基因的存在
每个物种的程序。由于实验环境的限制,其作用机制尚不清楚。
调节人类心脏发生的独特方面,以及人类特有的机制如何与
用于微调人类心脏发育的保守基因程序。最近,越来越多的证据
证明了长非编码RNA(LncRNAs)在细胞命运调控和
器官发生,包括心脏。LncRNA是大于200bp的非编码转录本,这解释了
>;40%的人类转录组。许多lncRNA具有组织特异性和物种特异性。最近,我们确定了
一个新的人类特异的LncRNA,命名为心脏制动LncRNA1(HBL1)(Dev.牢房。2017年,4:333-8)。HBL1是
高表达于人诱导多能干细胞(HiPSCs)的胞浆和胞核。胞质
HBL1通过抑制microRNA1(MIR1)来调节HiPSCs的心肌细胞发育。
多能标记基因SOX2激活HBL1转录。在这个提案中,我们将进一步分析一部小说
核HBL1与多聚体相互作用启动心脏基因表达程序的机制
抑制性复合体2(PRC2)。此外,我们将测试一个假设,即HBL1增加了一层新的人类-
在保守的心力轴之上的特定调节机制。总而言之,中心假设是
转录因子SOX2、lncRNA HBL1、microRNA-1和PrC2复合体组成一个完整网络
从多能干细胞控制人类心脏的生成。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lei Yang其他文献
Lei Yang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lei Yang', 18)}}的其他基金
Deciphering a Novel LncRNA-mediated Lipid Droplet Transport System in Human Heart
破译人类心脏中新型 LncRNA 介导的脂滴转运系统
- 批准号:
10640148 - 财政年份:2022
- 资助金额:
$ 48.86万 - 项目类别:
Transcriptional Factor SOX2, LncRNA HBL1, microRNA1 and PRC2 Epigenetic Complex Compose a Network to Orchestrate Cardiac Differentiation from Human Pluripotent Stem Cells
转录因子 SOX2、LncRNA HBL1、microRNA1 和 PRC2 表观遗传复合物组成一个网络来协调人类多能干细胞的心脏分化
- 批准号:
9796511 - 财政年份:2019
- 资助金额:
$ 48.86万 - 项目类别:
Transcriptional Factor SOX2, LncRNA HBL1, microRNA1 and PRC2 Epigenetic Complex Compose a Network to Orchestrate Cardiac Differentiation from Human Pluripotent Stem Cells
转录因子 SOX2、LncRNA HBL1、microRNA1 和 PRC2 表观遗传复合物组成一个网络来协调人类多能干细胞的心脏分化
- 批准号:
10463693 - 财政年份:2019
- 资助金额:
$ 48.86万 - 项目类别:
Transcriptional Factor SOX2, LncRNA HBL1, microRNA1 and PRC2 Epigenetic Complex Compose a Network to Orchestrate Cardiac Differentiation from Human Pluripotent Stem Cells
转录因子 SOX2、LncRNA HBL1、microRNA1 和 PRC2 表观遗传复合物组成一个网络来协调人类多能干细胞的心脏分化
- 批准号:
10688201 - 财政年份:2019
- 资助金额:
$ 48.86万 - 项目类别:
Embryonic stem cell/induced Pluripotent stem cell growth and gene editing core
胚胎干细胞/诱导多能干细胞生长和基因编辑核心
- 批准号:
10495947 - 财政年份:2017
- 资助金额:
$ 48.86万 - 项目类别:
Toward Regeneration of Whole Bioartificial Human Heart
走向整个生物人工心脏的再生
- 批准号:
8749862 - 财政年份:2014
- 资助金额:
$ 48.86万 - 项目类别:
相似海外基金
Integrating CRISPR-Cas Technology into Organic Electronics for Rapid Point-of-Care Genotyping
将 CRISPR-Cas 技术集成到有机电子器件中以实现快速护理点基因分型
- 批准号:
BB/X003442/1 - 财政年份:2023
- 资助金额:
$ 48.86万 - 项目类别:
Research Grant
Platform for CRISPR/Cas technology and AAV atherosclerosis model (S03)
CRISPR/Cas技术和AAV动脉粥样硬化模型平台(S03)
- 批准号:
408096640 - 财政年份:2018
- 资助金额:
$ 48.86万 - 项目类别:
Collaborative Research Centres